COVID19 vaccination program in Sri Lanka

0
1601
Sri Lanka COVID19 Vaccination Program Rollout India AstraZeneca Russia SputnikV China Sinopharm vaccines
Sri Lanka COVID19 Vaccination Program Rollout AstraZeneca SputnikV Sinopharm vaccines

Update – Folliwing the Western Province, the Covid-19 vaccination programme will continue in the Kandy, Kurunegala & Ratnapura districts – Health Minister Pavithra Wanniarachchi, reports Adaderana.

More than one million first doses of the coronavirus vaccines have been administered in Sri Lanka, according to the Government Information. Sri Lanka reaches 1 million milestone for Covid-19 vaccinations program. More than 1 million Sri Lankans had received their first dose of a COVID-19 as at May 12th.

Sri Lanka’s COVID19 Vaccine Rollout Tracking. (May 12)

India – AstraZeneca – 925,242 (1st jab) / 231,557 (2nd)
Russia – SputnikV – 14,673 (1st jab)
China – Sinopharm – 150,606 (1st jab)

Sri Lanka’s COVID19 Vaccine Rollout Tracking. May 11

India – AstraZeneca – 925,242 (1st jab) / 221,368 (2nd)
Russia – SputnikV – 11,338 (1st jab)
China – Sinopharm – 71,203 (1st jab)

Government to use ‘ITUKAMA’ COVID-19 Healthcare Fund balance Rs. 1360 Million for the vaccine roll-out.

PMD media release

Sri Lanka’s COVID19 Vaccine Rollout Tracking

India – AstraZeneca – 925,242 (1st jab) / 196,546 (2nd)
Russia – SputnikV – 4381 (1st jab)
China – Sinopharm – 3169 (1st jab)

Sri Lanka received 500,000 doses of AstraZeneca vaccine free of charge and the government purchased another 500,000 vaccines. We received another consignment of 265,000 vaccine doses. Accordingly, Sri Lanka received a total of 1,265,000 doses of AstraZeneca vaccine.

Under the first phase of the COVID-19 vaccination drive, around 925,000 people were given the first jab of the vaccine. However, the recent developments in India obstructed in getting down vaccines required for the second dose.

The health authorities have pointed out that around 600,000 doses of AstraZeneca vaccine are required to complete the second dose of the vaccination. The government is currently in discussions with various parties to obtain the required AstraZeneca vaccine doses.

Meanwhile, Sri Lanka received a donation of 600,000 doses of Chinese Sinopharm vaccine, which was not earlier approved by the World Health Organization.

However, as a result of a discussion President Gotabaya Rajapaksa held with the Director-General of the World Health Organization (WHO) via ‘Zoom’ last Friday, the WHO on the same evening approved the emergency use of the “Sinopharm ” vaccine.

Accordingly, the “Sinopharm” vaccination programme was commenced from the very next day of receiving approval and the government is making arrangements to vaccinate 25,000 people per day in the Western Province under the first phase.

Negotiations held with the Chinese authorities to obtain three million doses of Sinopharm vaccine have been successful and the government has made plans to commence the vaccination programmes in other provinces too as soon as the vaccines are received. The government has decided to use Russia’s Sputnik vaccine as well in the vaccination drive. Under the first phase of this, Sri Lanka received 15,000 doses of vaccines.

Since the vaccination method of Sputnik is slightly different from the methods used for other vaccines, our healthcare sector commenced the vaccination from the Gothatuwa area adopting the new methodology.

Under its second phase, 85,000 more Sputnik vaccines will be received soon. The President is confident that Sri Lanka will be able to successfully manage the current situation through vaccination, similar to the successful results achieved in the United States, the United Kingdom and a number of European countries through vaccination. The President is also fully confident in Sri Lanka’s robust healthcare system and the entire staff members of the healthcare sector.

A total of 925,242 persons have received the first dose of the AstraZeneca vaccine in Sri Lanka. A total of 2996 persons have received the first dose of the SputnikV vaccine. A total of 293 Sri Lankans have received the first dose of the Sinopharm. According to the Epidemiology Unit latest data, 194,905 persons who received the AstraZeneca vaccine were fully vaccinated by 8 May. meanwhile 2,865 doses of the Sinopharm vaccine as the first dose and 2,435 doses as the second dose was administered to Chinese nationals in Sri Lanka engaged in developmental activities.

Sri Lanka COVID19 Vaccination Program Details / Rollout

India – AstraZeneca – 925,242 (1st jab) / 194,905 (2nd)
Russia – SputnikV – 2996 (1st jab)
China – Sinopharm – 293 (1st jab)

Progress of COVID-19 Immunization Vaccine rollout in Sri Lanka

January 29, The COVID-19 vaccination drive kicked off in Sri Lanka, a day after India’s gift of 5 lakh doses of Covishield vaccine reached the island nation. The drive was began at the Army Hospital in Narahenpita as frontline workers fighting COVID-19 were vaccinated with the ‘Made in India’ Covishield vaccine.

May 6, Sri Lanka commenced administering the Sputnik V vaccine for COVID-19 developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia. Inoculation with the Russian Sputnik V vaccine commenced May 06 at the Madinnagoda Raja Maha Viharaya in the Gothatuwa Medical Officer of Health Division. Residents of Gothatuwa between the ages of 30 and 60 were the first to receive the Sputnik V vaccine. The first consignment of 15,000 doses of the Sputnik V vaccine arrived in Sri Lanka Tuesday (May 4) and 13 million doses will be received in installments in the near future. The National Medicines Regulatory Authority (NMRA) had in March approved the use of the Sputnik V COVID-19 vaccine in Sri Lanka and the Sri Lanka cabinet approved the purchase 7 million doses of Sputnik V vaccine at a cost of US$ 69.65 million.

May 8, Sri Lanka began rolling out the Sinopharm vaccine for COVID-19 developed by the China. Residents of Panadura between 30 and 60 were the first to be administered with the Sinopharm vaccine at the MOH office.

LEAVE A REPLY

Please enter your comment!
Please enter your name here